InnoGene Co

InnoGene Co EBIT per Share

The EBIT per Share of InnoGene Co (344860.KQ) as of Oct 9, 2026 is 52.73 KRW. In the previous year, EBIT per Share was 105.41 KRW — a change of -49.98% (lower).

EBIT per Share

52.73KRW

YoY

-49.98%

Last updated:

EBIT per Share of InnoGene Co is 2024 52.73 KRW. EBIT per Share of InnoGene Co was 2023 105.41 KRW. It decreases by -49.98% lower compared to the previous year.

The InnoGene Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
42.40 KRW
Jan 1, 2019
-253.80 KRW
Jan 1, 2020
120.98 KRW
Jan 1, 2021
257.90 KRW
Jan 1, 2022
159.96 KRW
Jan 1, 2023
105.41 KRW
Jan 1, 2024
52.73 KRW
The InnoGene Co EBIT per Share history
YEAREBIT per ShareYoY
52.73KRW-49.98%
105.41KRW-34.10%
159.96KRW-37.98%
257.90KRW+113.18%
120.98KRW-147.67%
-253.80KRW-698.58%
42.40KRW—
Access this data via the Eulerpool API
Get Free API Key

InnoGene Co Stock analysis

What does InnoGene Co do? InnoGene Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InnoGene Co stock

EBIT per Share of InnoGene Co is 52.73 KRW in 2024.

EBIT per Share of InnoGene Co changed from 105.41 KRW to 52.73 KRW, representing a -49.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share InnoGene Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — InnoGene Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — InnoGene Co